Volastra
1 follower
Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and p... Read more
Org chart
Scott Drutman
Head Of R&d And Chief Medical Officer
Collapse
Adriana Roopnariane
Senior Research Associate
Sarah Bettigole
Vp, Head Of Immunology And Data Science
Derek Cogan
Senior Vice President, Chemistry
Linda Lee
Senior Director Clinical Science
Jacqueline Gonzalez
Executive Administrative Assistant Office Manager
Ryan Schulz
Senior Research Associate
Nazario Bosco
Associate Director Of Biology
Board & advisors
Sandi Peterson
Chair
Samuel Bakhoum
Director
Luc Dochez
Director
Amy Schulman
Director
Lewis Cantley
Advisor
David Pellman
Advisor
Duane Compton
Advisor
David Baltimore
Advisor
Karen Vousden
Advisor
Tarun Kapoor
Advisor
Gerard Evan
Advisor
Herald Varmus
Advisor
Hans Clevers
Advisor
Olivier Elemento
Advisor
Stefan Vitorovic
Director
Arjun Balar
Board Member
Offices
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
2 followers
Eikon Therapeutics
4 followers
Gilead Sciences
206 followers
Regeneron
178 followers
Illumina
90 followers
Agilent Technologies
98 followers
Verily Life Sciences
49 followers
Alexion Pharmaceuticals
56 followers